Show simple item record

dc.contributor.authorTumwine, Lynnette K.
dc.contributor.authorOrem, Jackson
dc.contributor.authorKerchan, Patrick
dc.contributor.authorByarugaba, Wilson
dc.contributor.authorPileri, Stefano A.
dc.date.accessioned2021-12-12T18:10:20Z
dc.date.available2021-12-12T18:10:20Z
dc.date.issued2010
dc.identifier.citationTumwine et al., EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda Infectious Agents and Cancer 2010, 5:12. doi: 10.1186/1750-9378-5-12en_US
dc.identifier.other10.1186/1750-9378-5-12
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/374
dc.description.abstractB cell non Hodgkin lymphomas account for the majority of lymphomas in Uganda. The commonest is endemic Burkitt lymphoma, followed by diffuse large-B-cell lymphoma (DLBCL). There has been an increase in incidence of malignant lymphoma since the onset of the HIV/AIDS pandemic. However, the possible linkages of HHV8 and EBV to the condition of impaired immunity present in AIDS are still not yet very clearly understood.en_US
dc.language.isoenen_US
dc.publisherUganda Infectious Agents and Canceren_US
dc.subjectEBVen_US
dc.subjectHHV8en_US
dc.subjectHIVen_US
dc.subjectB cell non Hodgkin lymphomaen_US
dc.subjectUgandaen_US
dc.titleEBV & HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record